Bromazepam
1Provenance card
the boundary, as counts
Sources
4416 with DOI
12 strong · 22 moderate · 10 weak
Compilations
12026-05-09T12:15:47.089Z
pipeline-v5 · prompt hash not recorded — run predates 2026-09
Decisions
34last ruled 2026-06-04
1 awaiting a ruling
Issued documents
42026-10-19T20:30:50.429Z
notice · info card · emergency
Searches
191 with no results
queries and counts on the build
Claims checked
17410 supported
10 supported · 164 not
Correspondence
0received
consent field ships in Phase 4
Edges
501
derivations recorded for this entity
Complete over 44 sources, 1 compilation, and 34 decisions.Not here: the private journal (never); 1 proposal awaiting a ruling (listed as pending only).Working material — drafts, discards, unsupported claims — is listed below and readable on the working page.Cite: psychedex.org/substances/bromazepam/archive
Timeline
what happened, newest first — claims, searches and artifacts stay inside Build
- 2026-10-19issueIssued info_card
- 2026-10-02srcThe bioavailability of bromazepam, omeprazole and paracetamol given by nasogastric feeding tube.
- 2026-10-02srcPharmacological characterization of benzodiazepine receptors in the brain
- 2026-10-02srcFirst evaluation of the anxiolytic-like effects of a bromazepam-palladium complex in mice.
- 2026-10-02srcAutopsy case of intoxication with multiple psychotropic drugs.
- 2026-10-02srcInvolvement of the GABAA receptor alpha subunit in the mode of action of etifoxine.
- 2026-10-02srcPersistence of cognitive effects after withdrawal from long-term benzodiazepine use: a meta-analysis
- 2026-10-02srcAGNP Consensus Guidelines for Therapeutic Drug Monitoring in Psychiatry: Update 2011.
- 2026-10-02srcConsensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2017
- 2026-10-02srcPharmacobezoar-Related Fatalities: A Case Report and Review.
- 2026-10-02srcPlanned complex suicide involving combined drug intoxication and femoral catheterization.
- 2026-10-02srcBenzodiazepine use and risk of dementia: prospective population based study
- 2026-10-02srcProdynorphin gene deletion increased anxiety-like behaviours, impaired the anxiolytic effect of bromazepam and altered GABAA receptor subunits.
- 2026-10-02srcClinical Pharmacokinetics of Anxiolytics and Hypnotics in the Elderly
- 2026-10-02srcBenzodiazepine Dependence: Clinical and Molecular Aspects, Preventive Strategies and Therapeutic Approaches.
- 2026-10-02srcPrescription of Controlled Substances: Benefits and Risks
- 2026-10-02srcThe history of benzodiazepines
- 2026-10-02srcComparative bioavailability of two oral formulations of bromazepam in healthy volunteers.
- 2026-10-02srcA review of 19 double-blind placebo-controlled studies in social anxiety disorder.
- 2026-10-02srcMethcathinone: a new postindustrial drug.
- 2026-10-02srcSPE-HPLC-MS-MS quantification of bromazepam in human plasma: bioequivalence study.
- 2026-10-02srcDouble-blind, comparative study of cyamemazine vs. bromazepam in the benzodiazepine withdrawal syndrome.
- 2026-10-02srcBromazepam in generalized anxiety. Randomized, multi-practice comparisons with both chlorprothixene and placebo.
- 2026-10-02srcControlled comparison of two anxiolytic benzodiazepines, cloxazolam and bromazepam.
- 2026-10-02srcProtracted deep coma after bromazepam poisoning.
- 2026-10-02srcMetabolism of benzodiazepine and non-benzodiazepine anxiolytic-hypnotic drugs.
- 2026-10-02srcEffect of food on the bioavailability of bromazepam following oral administration in healthy volunteers.
- 2026-10-02srcA comparison between bromazepam (Ro 5-3350, Lexotan) and diazepam (Valium) in anxiety neurosis. A controlled, double-blind clinical trial.
- 2026-10-02srcEtizolam in the treatment of generalized anxiety disorder: a controlled clinical trial
- 2026-10-02srcBromazepam pharmacokinetics: influence of age, gender, oral contraceptives, cimetidine, and propranolol.
- 2026-10-02srcBromazepam and diazepam in generalized anxiety: a placebo-controlled study with measurement of drug plasma concentrations.
- 2026-10-02srcBenzodiazepines: a summary of pharmacokinetic properties.
- 2026-10-02srcBioavailability of bromazepam in man after single administration of an oral solution.
- 2026-10-02srcAction of benzodiazepines on spinal dorsal root reflex potentials in cats.
- 2026-10-02srcClinical pharmacokinetics of fluvoxamine.
- 2026-10-02srcComparison of tenoxicam and bromazepam in the treatment of fibromyalgia: randomized, double-blind, placebo-controlled trial.
- 2026-10-02srcOverview of the pharmacokinetics of fluvoxamine.
- 2026-10-02srcSelective serotonin reuptake inhibitors and CNS drug interactions. A critical review of the evidence.
- 2026-10-02srcPreoperative anxiolysis with minimal sedation in elderly patients: bromazepam or clorazepate?
- 2026-10-02srcBromazepam versus diazepam in psychoneurotic inpatients.
- 2026-10-02srcBromazepam — Wikidoc
- 2026-10-02srcUK Controlled Drugs List — GOV.UK
- 2026-10-02srcLexotan (Bromazepam) — PBS Listing
- 2026-10-02srcLexotan (Bromazepam) Prescribing Information (Roche Australia)
- 2026-10-02srcLexotan (Bromazepam) — TGA Australia (ARTG 52270)
- 2026-09-04issueIssued emergency
- 2026-09-04issueIssued info_card
- 2026-09-04issueIssued notice
- 2026-08-19revisionr1.a1
- 2026-07-03proposaldependence · taper
- 2026-06-04proposal30 value proposals approved togetherone review action inferred from a shared reviewer and instant — the graph records one activity per proposal
- 2026-06-04publicationPublication — backfill
- 2026-05-09revisionRevision 1
- 2026-05-09absenceSearched PubMed for "bromazepam half-life plasma protein binding" — no results
- 2026-05-09genGeneration — pipeline-v5 · with 3 morepipeline-v5
- 2026-05-09rungeneration run
The same entries, as forms: six forms.